Doctors from MD Anderson and Houston Methodist Hospital have performed what is believed to be the world’s first partial skull and scalp transplant on a man whose treatment for a rare cancer of the scalp muscle left him with a deep head wound.
During the same surgery, the patient also received a donor kidney and pancreas.
“This has been a long journey, and I am so grateful to all the doctors who performed my transplants,”...
Results of an MD Anderson clinical trial may change the perspective on a role for combination chemotherapy in advanced prostate cancer.
Two MD Anderson faculty members were awarded by the American Society for Clinical Oncology (ASCO) at the society’s annual meeting earlier...
Whole brain radiation to treat cancer that has spread to the brain is associated with significantly worse cognitive function than radiosurgery, and should no longer be used after radiosurgery to kill the cancer, according to a study led by an MD Anderson researcher.
Paul Brown, M.D., professor of Radiation Oncology, presented the results at the annual American Society for Clinical Oncology meeting held recently in Chicago....
MD Anderson and Madison, Wis.-based Exact Sciences Corp. have announced a partnership to co-develop and commercialize several blood-based...
MD Anderson Cancer Center has received more than $9 million in research grants in the latest round of funding from the Cancer Prevention and...